Stockscreener 앱 받기
2.285
4.65%
0.135
전일 마감가:
$2.15
열려 있는:
$2.08
하루 거래량:
20.93M
Relative Volume:
1.33
시가총액:
$106.86M
수익:
$1.20M
순이익/손실:
$-52.41M
주가수익비율:
-2.511
EPS:
-0.91
순현금흐름:
$-31.25M
1주 성능:
+19.05%
1개월 성능:
+345.54%
6개월 성능:
+108.33%
1년 성능:
-6.64%
1일 변동 폭
$2.06
$2.60
1주일 범위
$1.42
$2.60
52주 변동 폭
$0.387
$3.87
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
명칭
Rani Therapeutics Holdings Inc
전화
(408) 457-3700
주소
2051 RINGWOOD AVENUE, SAN JOSE
RANI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
2.269 | 209.71M | 1.20M | -52.41M | -31.25M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.25 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
631.09 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.06 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.92 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.68 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-02 | 개시 | Oppenheimer | Outperform |
| 2024-06-14 | 개시 | Maxim Group | Buy |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2023-04-17 | 재개 | BTIG Research | Buy |
| 2022-10-11 | 개시 | UBS | Buy |
| 2022-07-27 | 개시 | H.C. Wainwright | Buy |
| 2022-06-13 | 개시 | Wedbush | Outperform |
모두보기
Rani Therapeutics Holdings Inc 주식(RANI)의 최신 뉴스
Will Rani Therapeutics Holdings Inc. stock reach all time highs in 2025Wall Street Watch & Reliable Intraday Trade Alerts - newser.com
Is Rani Therapeutics Holdings Inc. stock trading at a premium valuationRate Hike & Verified Momentum Stock Watchlist - newser.com
Can momentum traders help lift Rani Therapeutics Holdings Inc.July 2025 PostEarnings & Advanced Swing Trade Entry Plans - newser.com
Rani Therapeutics: Underdog to Top Performer? - StocksToTrade
Can Rani Therapeutics Holdings Inc. stock maintain growth trajectoryJuly 2025 Institutional & Smart Investment Allocation Tips - newser.com
Short interest data insights for Rani Therapeutics Holdings Inc.Earnings Recap Report & Consistent Return Strategy Ideas - newser.com
How high can Rani Therapeutics Holdings Inc. stock goMarket Growth Report & Community Consensus Stock Picks - newser.com
Will Rani Therapeutics Holdings Inc. stock attract more institutional investors - newser.com
Will Rani Therapeutics Holdings Inc. bounce back from current supportBuy Signal & Community Verified Watchlist Alerts - newser.com
Institutional scanner results for Rani Therapeutics Holdings Inc.Weekly Trade Review & Daily Chart Pattern Signal Reports - newser.com
How Rani Therapeutics Holdings Inc. stock benefits from global expansionCEO Change & Verified Short-Term Plans - newser.com
Is Rani Therapeutics Holdings Inc. stock a buy for dividend growthDividend Hike & Weekly High Return Stock Forecasts - newser.com
MSN Money - MSN
Multi asset correlation models including Rani Therapeutics Holdings Inc.Buy Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Rani Therapeutics Holdings Inc. stock supported by innovation pipelineQuarterly Portfolio Review & Consistent Growth Equity Picks - newser.com
Weiss Ratings Reiterates Sell (D-) Rating for Rani Therapeutics (NASDAQ:RANI) - MarketBeat
Rani Therapeutics’ Strategic Partnerships Elevate Market Presence - timothysykes.com
H.C. Wainwright Initiates Rani Therapeutics (RANI) with Buy and $11 PT on RaniPill Potential - MSN
How to integrate Rani Therapeutics Holdings Inc. into portfolio analysis toolsJuly 2025 Selloffs & AI Forecast for Swing Trade Picks - newser.com
Promising Penny Stocks To Follow TodayOctober 21st - MarketBeat
Rani Therapeutics Holdings (RANI) Price Target Increased by 20.00% to 10.71 - MSN
Technical analysis overview for Rani Therapeutics Holdings Inc. stock2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com
Rani Therapeutics Holdings, Inc. (RANI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Rani Therapeutics Holdings, Inc. (RANI) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025 - The Manila Times
Rani (Nasdaq: RANI) to present RT-116 bioequivalence data in dogs at ObesityWeek 2025 - Stock Titan
Rani Therapeutics (NASDAQ:RANI) Director Mir Imran Buys 2,083,334 Shares - MarketBeat
Rani Therapeutics Hits New 52-Week High of $3.87, Marking Major Milestone - Markets Mojo
Hedge Fund and Insider Trading News: Ray Dalio, Bill Ackman, Israel Englander, Ken Griffin, Michael Burry, Warren Buffett, ExodusPoint Capital, Rani Therapeutics Holdings Inc (RANI), Coca-Cola Co (KO), and More - Insider Monkey
Rani Therapeutics Launches Phase 1 Study for Obesity Treatment RT-114 - MSN
Rani Therapeutics Holdings Insider Bought Shares Worth $1,260,417, According to a Recent SEC Filing - MarketScreener
Rani Therapeutics Holdings Inc (RANI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Rani Therapeutics Holdings Inc 주식 (RANI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| South Cone Investments Limited | 10% Owner |
Oct 21 '25 |
Sale |
2.77 |
4,000,000 |
11,074,000 |
2,379,194 |
| South Cone Investments Limited | 10% Owner |
Oct 20 '25 |
Sale |
2.41 |
1,923,000 |
4,637,314 |
6,379,194 |
| McKinley Kate | Chief Business Officer |
Dec 13 '24 |
Buy |
1.67 |
17,960 |
29,993 |
17,960 |
| Imran Talat | Chief Executive Officer |
Dec 09 '24 |
Buy |
1.94 |
10,296 |
19,974 |
494,751 |
1.02%
0.86%
자본화:
|
볼륨(24시간):